Globe Life Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Globe Life Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- GL
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000320335
Board of directors
-
Alice S. Cho · DirectorSince 2023
-
Cheryl Alston · DirectorSince 2023
-
Darren M. Rebelez · DirectorSince 2023
-
David A. Rodriguez · DirectorSince 2023
-
Derek T. Kan · DirectorSince 2026
-
Frank M. Svoboda · Director · Co-Chairman & CEOSince 2023
-
Gary L. Coleman · Director · Co-ChairmanSince 2023
-
James Brannen · DirectorSince 2023
-
James Matthew Darden · Director · Co-Chairman & CEOSince 2023
-
Larry M. Hutchison · Director · Co-ChaimanSince 2023
-
Linda Addison · DirectorSince 2023
-
Marilyn A. Alexander · DirectorSince 2023
-
Mark A. Blinn · DirectorSince 2023
-
Mary E. Thigpen · DirectorSince 2023
-
Matthew J. Adams · DirectorSince 2025
-
Melissa Jane Buchan · DirectorSince 2023
-
Philip M. Jacobs · DirectorSince 2025
-
Robert W. Ingram · DirectorSince 2023
-
Sandra Phillips Rogers · DirectorSince 2026
-
Steven Paul Johnson · DirectorSince 2023
Chief executives
Frank M. Svoboda
· Co-Chairman & CEO
Dates unknown
James Matthew Darden
· Co-Chairman & CEO
Dates unknown
Board connections
9 of this board's directors also sit on 14 other boards.
- via Alice S. Cho and James Brannen
- via Darren M. Rebelez
- via Mark A. Blinn
- via Derek T. Kan
- via Darren M. Rebelez
- via Mary E. Thigpen
- via Melissa Jane Buchan
- via Sandra Phillips Rogers
- via Derek T. Kan
- via Matthew J. Adams
- via Mark A. Blinn
- via Mark A. Blinn
- via Sandra Phillips Rogers
- via Derek T. Kan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $89,869,681
- 80 sales by 12 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Hensley Robert Edward Officer (EVP & Chief Investment Officer) | Option exercise | +10,000 | $103.23 | $1,032,300 |
| Sep 22, 2026 | Hensley Robert Edward Officer (EVP & Chief Investment Officer) | Open-market sale | −3,344 | $169.53 | $566,912 |
| Sep 22, 2026 | Hensley Robert Edward Officer (EVP & Chief Investment Officer) | Open-market sale | −6,656 | $170.34 | $1,133,789 |
| Aug 7, 2026 | MITCHELL ROBERT BRIAN Officer (EVP, General Counsel and CRO) | Option exercise | +23,000 | $103.23 | $2,374,290 |
| Aug 7, 2026 | MITCHELL ROBERT BRIAN Officer (EVP, General Counsel and CRO) | Open-market sale | −11,454 | $182.77 | $2,093,411 |
| Aug 7, 2026 | MITCHELL ROBERT BRIAN Officer (EVP, General Counsel and CRO) | Open-market sale | −10,529 | $183.83 | $1,935,545 |
| Aug 7, 2026 | MITCHELL ROBERT BRIAN Officer (EVP, General Counsel and CRO) | Open-market sale | −1,017 | $184.75 | $187,892 |
| Jul 31, 2026 | James Matthew Darden Director, Officer (Co-Chairman & CEO) | Option exercise | +50,000 | $98.32 | $4,916,000 |
| Jul 31, 2026 | James Matthew Darden Director, Officer (Co-Chairman & CEO) | Open-market sale | −49,600 | $182.43 | $9,048,295 |
| Jul 31, 2026 | James Matthew Darden Director, Officer (Co-Chairman & CEO) | Open-market sale | −400 | $183.36 | $73,343 |
| Jul 30, 2026 | Kalmbach Thomas Peter Officer (EVP & CFO) | Option exercise | +10,000 | $103.23 | $1,032,300 |
| Jul 30, 2026 | Kalmbach Thomas Peter Officer (EVP & CFO) | Option exercise | +11,000 | $120.49 | $1,325,390 |
| Jul 30, 2026 | Kalmbach Thomas Peter Officer (EVP & CFO) | Open-market sale | −10,720 | $179.30 | $1,922,066 |
| Jul 30, 2026 | Kalmbach Thomas Peter Officer (EVP & CFO) | Open-market sale | −4,840 | $180.08 | $871,578 |
| Jul 30, 2026 | Kalmbach Thomas Peter Officer (EVP & CFO) | Open-market sale | −2,650 | $181.23 | $480,255 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.